Graphical AbstractVerifiedA Novel Approach for Drug Discovery: Integrating Machine Learning and Molecular Dynamics Simulations
Drug discovery is a complex and time-consuming process. Traditional methods often fail to identify promising candidates efficiently. In this study, we propose a novel approach that integrates machine learning (ML) and molecular dynamics (MD) simulations to enhance the prediction of drug-target interactions. Our method employs a deep learning model trained on a large dataset of known interactions, followed by MD simulations to validate the stability of predicted complexes. We applied our approach to a set of kinase inhibitors and demonstrated improved accuracy compared to existing methods. The integration of ML and MD provides a robust pipeline for virtual screening, reducing false positives and accelerating the discovery of lead compounds. Our findings suggest that this hybrid strategy can significantly streamline the drug development process, offering a powerful tool for medicinal chemists.
